
Carlsmed, Inc. (CARL)
CARL Stock Price Chart
Explore Carlsmed, Inc. interactive price chart. Choose custom timeframes to analyze CARL price movements and trends.
CARL Company Profile
Discover essential business fundamentals and corporate details for Carlsmed, Inc. (CARL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
23 Jul 2025
Employees
127.00
Website
https://www.carlsmed.comCEO
Michael Cordonnier
Description
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
CARL Financial Timeline
Browse a chronological timeline of Carlsmed, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Aug 2026
EPS estimate is -$0.32, while revenue estimate is $18.96m.
Upcoming earnings on 21 Jul 2026
EPS estimate is -$0.43, while revenue estimate is $17.95m.
Earnings released on 5 May 2026
EPS came in at -$0.32 surpassing the estimated -$0.43 by +25.58%, while revenue for the quarter reached $16.12m , beating expectations by +7.84%.
Earnings released on 25 Feb 2026
EPS came in at -$0.32 surpassing the estimated -$0.43 by +25.58%, while revenue for the quarter reached $15.17m , beating expectations by +3.01%.
Earnings released on 6 Nov 2025
EPS came in at -$0.40 surpassing the estimated -$0.45 by +11.11%, while revenue for the quarter reached $13.07m , missing expectations by -12.01%.
Earnings released on 28 Aug 2025
EPS came in at -$1.47 surpassing the estimated -$1.52 by +3.29%, while revenue for the quarter reached $12.08m , beating expectations by +0.80%.
CARL Stock Performance
Access detailed CARL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.